CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A phase I trial of veliparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors.
Author
Andrea Elisabeth Wahner Hendrickson
Charles Erlichman
+11Â more
Donald W. Northfelt
Fleix Boakye-Agyeman
Guy G Poirier
Harry J. Long
Janet Lensing
Joel M. Reid
Karen S Flatten
Lynn C. Hartmann
Michael E. Menefee
Paul Haluska
Scott H. Kaufmann
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref